Evidence mapPaperPMID 39300231Full record

ArticleCommunications biology2024

Multiscale and multimodal evaluation of autosomal dominant polycystic kidney disease development.

Pablo Delgado-Rodriguez, Nicolás Lamanna-Rama, Cassondra Saande, Rafael Aldabe, María L Soto-Montenegro, Arrate Munoz-Barrutia

Abstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pablo Delgado-RodriguezBioengineering Department, Universidad Carlos III de Madrid, Madrid, Spain. pdelgado@pa.uc3m.es.ORCID 0000-0002-5991-7791
Nicolás Lamanna-RamaInstituto de Investigacion Sanitaria Gregorio Marañon (IiSGM), Madrid, Spain.
Cassondra SaandeDivision of Gene Therapy and Regulation of Gene Expression, Centre for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.ORCID 0000-0002-0763-7691
Rafael AldabeDivision of Gene Therapy and Regulation of Gene Expression, Centre for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.ORCID 0000-0002-9461-020X
María L Soto-MontenegroInstituto de Investigacion Sanitaria Gregorio Marañon (IiSGM), Madrid, Spain.
Arrate Munoz-BarrutiaBioengineering Department, Universidad Carlos III de Madrid, Madrid, Spain.ORCID 0000-0002-1573-1661

Funding

EC | European Regional Development Fund (Europski Fond za Regionalni Razvoj) RTC-2017-6600-1
6 · The paper itself

Abstract

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most prevalent kidney genetic disorder, producing structural abnormalities and impaired function. This research investigates its evolution on mouse models, utilizing a combination of histology imaging, Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) to evaluate its progression thoroughly. ADPKD has been induced in mice via PKD2 gene knockout, followed by image acquisition at different stages. Histology data provides two-dimensional details, like the cystic area ratio, whereas CT and MRI facilitate three-dimensional temporal monitoring. Our approach allows to quantify the affected tissue at different disease stages through multiple quantitative metrics. A pivotal point is shown at approximately ten weeks after induction, marked by a swift acceleration in disease advancement, and leading to a notable increase in cyst formation. This multimodal strategy augments our comprehension of ADPKD dynamics and suggests the possibility of employing higher-resolution imaging in the future for more accurate volumetric analyses.

Indexed as

Magnetic Resonance ImagingPolycystic Kidney, Autosomal DominantTomography, X-Ray ComputedAnimalsDisease Models, AnimalDisease ProgressionKidneyMiceMice, KnockoutMultimodal ImagingTRPP Cation ChannelsTRPP Cation Channels

Identifiers

PMID39300231
PMCPMC11412990

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.